Contineum Therapeutics News

Contineum Therapeutics Sets Executive Severance Plan

TipRanks18:00 ET

Stifel Nicolaus Sticks to Its Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)

TipRanksMay 20 22:05 ET

Express News | Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors

ReutersMay 20 16:05 ET

Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy From RBC Capital

TipRanksMay 17 06:27 ET

Contineum Therapeutics | 10-Q: Quarterly report

SEC announcementMay 16 17:04 ET · Announcements

Express News | Contineum Therapeutics Q3 EPS $(3.55), Cash Position $117.9M

BenzingaMay 16 16:26 ET

Express News | Contineum Therapeutics Inc - Qtrly Shr Loss $3.55

ReutersMay 16 16:10 ET

Contineum Therapeutics 1Q Loss/Shr $3.55 >CTNM

Contineum Therapeutics 1Q Loss/Shr $3.55 >CTNM

Dow JonesMay 16 16:06 ET

Express News | Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

ReutersMay 16 16:05 ET

Stifel, Morgan Stanley Bullish on Newly Public Contineum

Seeking AlphaApr 30 13:10 ET

Express News | Contineum Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $29

ReutersApr 30 06:44 ET

Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel

Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel

Dow JonesApr 30 05:30 ET

Contineum Therapeutics Initiated at Overweight by Morgan Stanley

Contineum Therapeutics Initiated at Overweight by Morgan Stanley

Dow JonesApr 30 05:25 ET

Express News | Morgan Stanley Initiates Coverage On Contineum Therapeutics With Overweight Rating, Announces Price Target of $25

BenzingaApr 30 05:15 ET

Contineum Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 58.83% Morgan Stanley → $25 Initiates Coverage On → Overweight

BenzingaApr 30 05:13 ET

Contineum Therapeutics: A Strategic Buy Amidst Promising Clinical Trials and Strong Revenue Projections

TipRanksApr 30 04:55 ET

Buy Rating Justified by Contineum Therapeutics' Diverse Pipeline and IPF Program Potential

TipRanksApr 30 04:55 ET

Express News | Contineum Therapeutics Inc : RBC Initiates Coverage With Outperform Rating; Price Target $30

ReutersApr 30 00:43 ET

NASDAQ New 52-Week Highs And Lows

New Highs 26 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Blue World Acqn Cl A BWAQ 11.27 211,893 C

Dow JonesApr 17 15:21 ET

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply during Tuesday's session following bette

BenzingaApr 16 10:15 ET